228 related articles for article (PubMed ID: 17373277)
1. [Biochemical markers of iron status].
Aimone-Gastin I
Nephrol Ther; 2006 Nov; 2 Suppl 5():S321-6. PubMed ID: 17373277
[TBL] [Abstract][Full Text] [Related]
2. Assessing iron status: beyond serum ferritin and transferrin saturation.
Wish JB
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
[TBL] [Abstract][Full Text] [Related]
3. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
4. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
5. [Anemia and iron metabolism in patients with type-2 diabetes mellitus].
Kovács F; Szakál I; Révész K; Lévai A; Dobos A
Orv Hetil; 2006 Feb; 147(8):345-9. PubMed ID: 16579333
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
Chang J; Bird R; Clague A; Carter A
Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
[TBL] [Abstract][Full Text] [Related]
7. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
8. Soluble transferrin receptor, ferritin and soluble transferrin receptor--Ferritin index in assessment of anaemia in rhaeumatoid arthritis.
Pavai S; Jayaranee S; Sargunan S
Med J Malaysia; 2007 Oct; 62(4):303-7. PubMed ID: 18551934
[TBL] [Abstract][Full Text] [Related]
9. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy.
Yavuz A; Akbaş SH; Tuncer M; Kolağasi O; Cetinkaya R; Gürkan A; Demirbaş A; Gultekin M; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):41-3. PubMed ID: 15013295
[TBL] [Abstract][Full Text] [Related]
10. [Soluble tranferrin receptor in the biological diagnosis of iron deficiency. Report of 24 cases].
Zorgati MM; Hafsia R; Bahlous A; Bahri S; Ben Ammar S
Tunis Med; 2009 Dec; 87(12):818-23. PubMed ID: 20209848
[TBL] [Abstract][Full Text] [Related]
11. Reticulocyte haemoglobin content vs. soluble transferrin receptor and ferritin index in iron deficiency anaemia accompanied with inflammation.
Marković M; Majkić-Singh N; Ignjatović S; Singh S
Int J Lab Hematol; 2007 Oct; 29(5):341-6. PubMed ID: 17824914
[TBL] [Abstract][Full Text] [Related]
12. Improved preoperative iron status assessment by soluble transferrin receptor in elderly patients undergoing knee and hip replacement.
Basora M; Deulofeu R; Salazar F; Quinto L; Gomar C
Clin Lab Haematol; 2006 Dec; 28(6):370-5. PubMed ID: 17105489
[TBL] [Abstract][Full Text] [Related]
13. Soluble transferrin receptors in anaemia of pregnancy.
Akinsooto V; Ojwang PJ; Govender T; Moodley J; Connolly CA
J Obstet Gynaecol; 2001 May; 21(3):250-2. PubMed ID: 12521853
[TBL] [Abstract][Full Text] [Related]
14. Influence of endurance exercise (triathlon) on circulating transferrin receptors and other indicators of iron status in female athletes.
Röcker L; Hinz K; Holland K; Gunga HC; Vogelgesang J; Kiesewetter H
Clin Lab; 2002; 48(5-6):307-12. PubMed ID: 12071581
[TBL] [Abstract][Full Text] [Related]
15. Elevated soluble transferrin receptor levels reflect increased erythropoietic drive rather than iron deficiency in pediatric sickle cell disease.
Lulla RR; Thompson AA; Liem RI
Pediatr Blood Cancer; 2010 Jul; 55(1):141-4. PubMed ID: 20486179
[TBL] [Abstract][Full Text] [Related]
16. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
Cermák J; Gregora E; Lachmanová J; Brabec V
Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
[TBL] [Abstract][Full Text] [Related]
17. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
Costa E; Pereira BJ; Rocha-Pereira P; Rocha S; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
Am J Nephrol; 2008; 28(4):677-83. PubMed ID: 18354252
[TBL] [Abstract][Full Text] [Related]
18. [The transferrin receptor: its role in iron metabolism and its diagnosis utility].
Vernet M
Ann Biol Clin (Paris); 1999; 57(1):9-18. PubMed ID: 9920962
[TBL] [Abstract][Full Text] [Related]
19. Evaluating iron status in hemodialysis patients.
Enders HM
Nephrol Nurs J; 2002 Aug; 29(4):366-70. PubMed ID: 12224370
[TBL] [Abstract][Full Text] [Related]
20. Iron metabolism in rhEPO-treated hemodialysis patients.
Schaefer RM; Bahner U
Clin Nephrol; 2000 Feb; 53(1 Suppl):S65-8. PubMed ID: 10746809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
